SCHEMBL27361672

SCHEMBL27361672

CCNC(=O)c1ccc(CO)o1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.68
TDP1 Q9NUW8 2/20 0.68
TSHR P16473 2/20 0.68
MAPK1 P28482 2/20 0.49
HPGD P15428 2/20 0.45
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GFER P55789 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20669705 0.84 TSHR (0.49) ALDH1A1TDP1TSHRMAPK1HPGD
SCHEMBL13451413 0.81 ALDH1A1 (0.62) ALDH1A1TDP1TSHRHPGDLMNA
SCHEMBL27362667 0.81 ALDH1A1 (0.62) ALDH1A1TDP1TSHRHPGDLMNA
SCHEMBL27363104 0.81 ALDH1A1 (0.62) ALDH1A1TDP1TSHRHPGDPOLB
SCHEMBL13761382 0.81 ALDH1A1 (0.54) ALDH1A1TDP1TSHRMAPK1HPGD
SCHEMBL7074467 0.81 ALDH1A1 (1.00) ALDH1A1TDP1TSHRHPGDLMNA
SCHEMBL13631426 0.78 HPGD (0.71) TSHRMAPK1HPGDPOLBHTT
SCHEMBL29332952 0.76 MAPK1 (0.50) ALDH1A1TDP1TSHRMAPK1HPGD
SCHEMBL13753317 0.76 ALDH1A1 (0.73) ALDH1A1TDP1MAPK1HPGDLMNA
SCHEMBL28791562 0.75 TDP1 (0.58) ALDH1A1TDP1TSHRLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050433-A1 ALLOSTERIC MODULATORS OF ANDROGEN RECEPTOR COACTIVATOR RECRUITMENT FOR CRPC THERAPY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2024-03-07 WO disclosed